相关实验视频
Updated: Jul 23, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
从长椅到床边:到目前为止,我们对伊米达佐提亚衍生物有什么了解?
Mu Guo1,2, Xiangbin Yu1,2, Yi Zhun Zhu3
1School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Molecules (Basel, Switzerland)
|July 14, 2023
概括
伊米达佐提亚衍生物具有显著的治疗潜力,具有多种不同的生理活动. 这篇评论强调了它们的抗瘤,抗感染,抗炎和抗氧化作用,指导了未来的药物开发.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊米达佐提亚衍生物在治疗中越来越突出.
- 这些化合物表现出显著的生理活动.
研究的目的:
- 为了审查伊米达佐提亚衍生物的药理效应.
- 总结它们的作用机制.
- 为了指导未来的药物开发.
主要方法:
- 关于伊米达佐醇衍生物的文献综述.
- 报告生物活动的分析.
- 药理学数据的综合.
主要成果:
- 伊米达佐提亚醇衍生物具有抗瘤性质.
- 它们表现出抗感染,抗炎和抗氧化作用.
- 不同的衍生品表现出不同的药理学特征.
结论:
- 伊米达佐提亚衍生物是药物发现的多功能支架.
- 了解它们的机制对于治疗进步至关重要.
- 这一审查为开发基于伊米达佐提亚的新药提供了基础.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
754
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
754
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
346
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
346
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
249
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
249
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
204
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
204
Drug Administration and Therapy Phases: Overview
555
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
555

